News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,990 Results
Type
Article (14599)
Company Profile (283)
Press Release (254108)
Section
Business (80061)
Career Advice (153)
Deals (13351)
Drug Delivery (42)
Drug Development (51177)
Employer Resources (31)
FDA (5844)
Job Trends (5220)
News (145861)
Policy (10268)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (914)
Accelerated approval (2)
Adcomms (26)
Allergies (49)
Alliances (21806)
ALS (62)
Alzheimer's disease (873)
Antibody-drug conjugate (ADC) (132)
Approvals (5844)
Artificial intelligence (111)
Autoimmune disease (10)
Automation (5)
Bankruptcy (105)
Best Places to Work (4654)
BIOSECURE Act (6)
Biosimilars (40)
Biotechnology (232)
Bladder cancer (45)
Brain cancer (20)
Breast cancer (166)
Cancer (1386)
Cardiovascular disease (102)
Career advice (132)
Career pathing (2)
CAR-T (112)
Cell therapy (311)
Cervical cancer (11)
Clinical research (41469)
Collaboration (507)
Compensation (219)
Complete response letters (15)
COVID-19 (1063)
CRISPR (36)
C-suite (143)
Cystic fibrosis (76)
Data (1367)
Denatured (11)
Depression (28)
Diabetes (129)
Diagnostics (1301)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (79)
Drug pricing (31)
Drug shortages (4)
Duchenne muscular dystrophy (81)
Earnings (29863)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48575)
Executive appointments (399)
FDA (6470)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (466)
Gene editing (87)
Generative AI (9)
Gene therapy (229)
GLP-1 (362)
Government (1107)
Grass and pollen (2)
Guidances (19)
Healthcare (6758)
Huntington's disease (21)
IgA nephropathy (20)
Immunology and inflammation (79)
Indications (18)
Infectious disease (1126)
Inflammatory bowel disease (111)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (56)
Interviews (17)
IPO (7322)
IRA (13)
Job creations (869)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (206)
Leadership (2)
Legal (1406)
Liver cancer (31)
Lung cancer (215)
Lymphoma (90)
Machine learning (1)
Management (7)
Manufacturing (125)
MASH (47)
Medical device (2602)
Medtech (2603)
Mergers & acquisitions (6317)
Metabolic disorders (370)
Multiple sclerosis (51)
NASH (14)
Neurodegenerative disease (57)
Neuropsychiatric disorders (23)
Neuroscience (1238)
NextGen: Class of 2025 (2040)
Non-profit (861)
Northern California (1553)
Now hiring (21)
Obesity (185)
Opinion (104)
Ovarian cancer (62)
Pain (41)
Pancreatic cancer (52)
Parkinson's disease (105)
Partnered (6)
Patents (114)
Patient recruitment (70)
Peanut (35)
People (25599)
Pharmaceutical (51)
Pharmacy benefit managers (5)
Phase I (14613)
Phase II (19242)
Phase III (12276)
Pipeline (697)
Podcasts (56)
Policy (38)
Postmarket research (861)
Preclinical (6107)
Press Release (30)
Prostate cancer (56)
Psychedelics (35)
Radiopharmaceuticals (215)
Rare diseases (272)
Real estate (1440)
Recruiting (12)
Regulatory (8780)
Reports (15)
Research institute (944)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (54)
Series A (92)
Series B (60)
Service/supplier (1)
Sickle cell disease (38)
Southern California (1361)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1974)
State (1)
Stomach cancer (9)
Supply chain (19)
The Weekly (43)
United States (12152)
Vaccines (219)
Venture capitalists (28)
Webinars (7)
Weight loss (108)
Women's health (15)
Worklife (2)
Date
Today (13)
Last 7 days (366)
Last 30 days (1592)
Last 365 days (20307)
2025 (4640)
2024 (20941)
2023 (22703)
2022 (27106)
2021 (28008)
2020 (23553)
2019 (16439)
2018 (11903)
2017 (13868)
2016 (11937)
2015 (14469)
2014 (10475)
2013 (7562)
2012 (7609)
2011 (7669)
2010 (7470)
Location
Africa (155)
Alabama (38)
Alaska (2)
Arizona (52)
Arkansas (5)
Asia (17563)
Australia (2928)
California (3513)
Canada (1048)
China (339)
Colorado (135)
Connecticut (145)
Delaware (93)
Europe (37413)
Florida (415)
Georgia (106)
Idaho (16)
Illinois (209)
India (9)
Indiana (85)
Iowa (1)
Japan (83)
Kansas (59)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (446)
Massachusetts (2766)
Michigan (70)
Minnesota (134)
Mississippi (1)
Missouri (23)
Montana (14)
Nebraska (4)
Nevada (16)
New Hampshire (14)
New Jersey (919)
New Mexico (12)
New York (969)
North Carolina (518)
North Dakota (4)
Northern California (1553)
Ohio (107)
Oklahoma (9)
Oregon (21)
Pennsylvania (668)
Puerto Rico (3)
Rhode Island (15)
South America (215)
South Carolina (4)
Southern California (1361)
Tennessee (25)
Texas (403)
Utah (48)
Virginia (67)
Washington D.C. (28)
Washington State (335)
Wisconsin (13)
268,990 Results for "adc therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company
March 18, 2025
·
10 min read
Antibody-drug conjugate
Next-Gen ADCs Driving ‘Renaissance’ in Already Hot Oncology Drug Class
ADC Therapeutics, Sutro Biopharma and Zai Lab are among those developing antibody-drug conjugates to address payload and toxicity challenges of current ADCs—and rapidly grow the multibillion-dollar market.
November 25, 2024
·
7 min read
·
Greg Slabodkin
Press Releases
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025
March 25, 2025
·
5 min read
Press Releases
Adcentrx Therapeutics to Showcase Novel STEAP1 and NaPi2b ADCs with Oral and Poster Presentations at AACR 2025
March 26, 2025
·
4 min read
Press Releases
ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update
March 28, 2025
·
20 min read
Press Releases
ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
January 30, 2025
·
1 min read
Press Releases
ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025
March 20, 2025
·
4 min read
Antibody-drug conjugate
Gilead Plots ADC Comeback With Potential $415M License Agreement
The deal with Tubulis will help Gilead regain its footing in the ADC space following the withdrawal of Trodelvy in bladder cancer and its late-stage fail in NSCLC.
December 3, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Myris Therapeutics is Developing Ultra-High DAR ADCs to Enable Novel Precision Medicine Treatments for Cancer
February 20, 2025
·
4 min read
Press Releases
Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer’s ADCs
February 25, 2025
·
4 min read
1 of 26,899
Next
